AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $262,000 | -45.2% | 34,838 | -26.9% | 0.01% | -40.0% |
| Q2 2022 | $478,000 | -16.7% | 47,638 | +2.8% | 0.02% | -4.8% |
| Q1 2022 | $574,000 | -84.0% | 46,338 | -70.4% | 0.02% | -83.5% |
| Q4 2021 | $3,578,000 | -27.0% | 156,458 | -29.4% | 0.13% | -39.2% |
| Q3 2021 | $4,904,000 | +272.9% | 221,633 | +118.5% | 0.21% | +287.0% |
| Q2 2021 | $1,315,000 | -7.5% | 101,433 | -7.3% | 0.05% | -8.5% |
| Q1 2021 | $1,422,000 | -35.5% | 109,420 | -31.4% | 0.06% | -30.6% |
| Q4 2020 | $2,205,000 | -8.8% | 159,441 | -2.8% | 0.08% | -26.1% |
| Q3 2020 | $2,417,000 | +3.3% | 164,108 | +14.0% | 0.12% | -12.9% |
| Q2 2020 | $2,340,000 | +218.4% | 143,958 | +184.4% | 0.13% | +127.6% |
| Q1 2020 | $735,000 | -9.0% | 50,625 | +26.8% | 0.06% | +28.9% |
| Q4 2019 | $808,000 | – | 39,922 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |